These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7346730)

  • 1. Drug development in pediatrics: problems and strategies. Overview and perspectives.
    Yaffe SJ
    Pediatr Pharmacol (New York); 1980; 1(1):3-5. PubMed ID: 7346730
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug development in pediatrics: problems and strategies. The point of view of the academic community.
    Soyka LF
    Pediatr Pharmacol (New York); 1980; 1(1):21-4. PubMed ID: 7346728
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug studies in children.
    Finkel MJ
    Pediatr Pharmacol (New York); 1980; 1(1):7-14. PubMed ID: 7346734
    [No Abstract]   [Full Text] [Related]  

  • 4. Pediatric drug testing enters infancy.
    Restivo J
    Nat Med; 2003 Jun; 9(6):631. PubMed ID: 12778145
    [No Abstract]   [Full Text] [Related]  

  • 5. Patient recruitment: US perspective.
    Walson PD
    Pediatrics; 1999 Sep; 104(3 Pt 2):619-22. PubMed ID: 10469803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Academy of Pediatrics Committee on Drugs. "Therapeutic orphans" and the package insert.
    Pediatrics; 1970 Nov; 46(5):811-3. PubMed ID: 5536437
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of pediatric drug formulations.
    Nahata MC
    Pediatrics; 1999 Sep; 104(3 Pt 2):607-9. PubMed ID: 10469800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current challenges in pediatric drug development.
    Adamson PC
    Clin Adv Hematol Oncol; 2008 Dec; 6(12):883-4. PubMed ID: 19209138
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceutical industry in pediatric drug development: partners and collaborators with academia and the FDA.
    Mulberg AE
    J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):711-3. PubMed ID: 18955888
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic orphans.
    Shirkey H
    Pediatrics; 1999 Sep; 104(3 Pt 2):583-4. PubMed ID: 10469793
    [No Abstract]   [Full Text] [Related]  

  • 11. Is pediatric labeling really necessary?
    Christensen ML; Helms RA; Chesney RW
    Pediatrics; 1999 Sep; 104(3 Pt 2):593-7. PubMed ID: 10469796
    [No Abstract]   [Full Text] [Related]  

  • 12. An update on the therapeutic orphan.
    Wilson JT
    Pediatrics; 1999 Sep; 104(3 Pt 2):585-90. PubMed ID: 10469794
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene therapy in pediatric medicine.
    Ledley FD
    Adv Pediatr; 1996; 43():1-25. PubMed ID: 8794173
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic orphans--everybody's business.
    Shirkey HC
    Ann Pharmacother; 2006 Jun; 40(6):1174. PubMed ID: 16735665
    [No Abstract]   [Full Text] [Related]  

  • 15. Pediatric drug trials. Challenge to FDA's authority may end up giving it more.
    Marshall E
    Science; 2002 May; 296(5569):820-1. PubMed ID: 11988539
    [No Abstract]   [Full Text] [Related]  

  • 16. Pediatric study of medicines becomes mandatory.
    Bonetta L
    Nat Med; 2000 Oct; 6(10):1069. PubMed ID: 11017118
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluating drugs for use in children.
    Thompson RC
    FDA Consum; 1975 Mar; 9(2):14-7. PubMed ID: 10308672
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug testing in children.
    Greene J
    FDA Consum; 1978 Jun; 12(5):11-3. PubMed ID: 10308116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug development process for a product with a primary pediatric indication.
    Allen AJ; Michelson D
    J Clin Psychiatry; 2002; 63 Suppl 12():44-9. PubMed ID: 12562061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA notifications. New labeling for Videx pediatric powder.
    AIDS Alert; 2009 Aug; 24(8):94-6. PubMed ID: 19705588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.